+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Microbiome Sequencing Services Market - Global Forecast 2026-2032- Product Image
Microbiome Sequencing Services Market - Global Forecast 2026-2032- Product Image
Sale

Microbiome Sequencing Services Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968642
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Microbiome Sequencing Services Market is projected to reach USD 323.71 Million in 2026. It is expected to continue growing at a CAGR of 11.33%, reaching USD 619.13 Million by 2032.

Microbiome sequencing services are becoming core infrastructure for precision health, pharmaceutical discovery, food safety, agriculture, environmental monitoring, and consumer wellness. Service providers combine sample preparation, 16S rRNA sequencing, shotgun metagenomics, metatranscriptomics, long-read sequencing, and bioinformatics to profile microbial communities with higher taxonomic and functional resolution.

Demand is supported by validated scientific programs such as the NIH Human Microbiome Project, expanding public repositories including NCBI Sequence Read Archive and MGnify, and broader adoption of next-generation sequencing in clinical and translational research. Buyers increasingly prioritize reproducible workflows, contamination control, metadata quality, secure data handling, and interpretable outputs that can support research decisions, product development, and regulatory documentation.

Transformative Shifts in the Microbiome Sequencing Landscape

The landscape is shifting from discovery-only microbiome profiling toward decision-grade microbial intelligence. Short-read platforms remain widely used for scalable 16S rRNA and shotgun metagenomic studies, while long-read sequencing improves genome assembly, strain tracking, plasmid and mobile genetic element analysis, and antimicrobial resistance gene context.

Service differentiation now depends on integrated wet-lab and bioinformatics quality. Customers expect standardized DNA extraction, spike-in and negative controls, host DNA depletion options, curated reference databases, and transparent pipelines using established tools such as QIIME 2, DADA2, Kraken, MetaPhlAn, HUMAnN, and assembly-based methods. The strongest providers also support multi-omics integration, longitudinal study design, sample-chain traceability, and compliant data governance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is improving microbiome sequencing services by accelerating quality control, taxonomic classification, functional annotation, biomarker discovery, and cohort stratification. Machine learning models can detect batch effects, flag low-biomass contamination patterns, prioritize microbial signatures, and integrate microbiome profiles with metabolomics, clinical variables, diet, geography, and medication exposure.

The most credible AI adoption is explainable and validation-led. Because microbiome datasets are compositional, sparse, and highly affected by collection and extraction methods, industry leaders are applying cross-validation, external cohort testing, model interpretability, and reproducible feature engineering. AI is therefore most valuable when paired with rigorous metadata standards, transparent bioinformatics, and human scientific review rather than treated as a standalone insight engine.

Key Regional Insights

North America remains a leading region for microbiome sequencing services due to strong academic medical centers, biopharma R&D, clinical research networks, venture-backed therapeutics, and mature next-generation sequencing infrastructure. Europe benefits from large public research networks, biobanking capacity, national genomics initiatives, and strong data-protection requirements that favor validated, privacy-aware workflows. Asia-Pacific is expanding rapidly as China, Japan, South Korea, India, Singapore, and Australia invest in genomics, population-scale research, probiotics, infectious disease monitoring, and agricultural biotechnology.

Latin America is gaining traction through infectious disease research, biodiversity studies, food systems, and growing sequencing capacity in Brazil and Mexico. The Middle East is investing in precision medicine, national genomics, healthcare modernization, and high-quality laboratory infrastructure, particularly across GCC economies. Africa’s opportunity is linked to infectious disease surveillance, soil and water microbiomes, antimicrobial resistance monitoring, agriculture resilience, and biodiversity research, although funding continuity, sample logistics, workforce development, and local sequencing infrastructure remain critical constraints.

Key Group Insights

ASEAN demand is supported by Singapore’s biomedical ecosystem, Thailand and Malaysia’s food and agriculture research, and regional interest in infectious disease, gut health, probiotics, aquaculture, and environmental microbiomes. GCC countries are emphasizing precision medicine, hospital modernization, national health programs, and population health initiatives that create demand for secure, clinically aligned microbiome sequencing workflows. The European Union’s research funding, harmonized regulatory environment, cross-border scientific collaboration, and GDPR-driven data standards encourage robust consent, traceability, privacy protection, and reproducibility.

BRICS countries combine large populations, diverse diet and exposure profiles, public health needs, agricultural priorities, and expanding sequencing capacity, making them important centers for cost-efficient microbiome sequencing services. G7 markets continue to lead in pharmaceutical applications, companion diagnostics research, regulated clinical studies, and advanced multi-omics integration. NATO countries, while not a commercial bloc, collectively influence biosecurity, pathogen surveillance, antimicrobial resistance monitoring, and resilient laboratory networks relevant to microbiome sequencing providers.

Key Country Insights

The United States leads through NIH-funded microbiome research, biotech innovation, contract research networks, hospital-linked translational programs, and strong demand from pharma, nutrition, and clinical research. Canada contributes through population health, environmental microbiology, Indigenous and northern health research frameworks, and academic consortia, while Mexico and Brazil show rising demand in infectious disease, agriculture, food systems, and biodiversity studies. The United Kingdom, Germany, France, Italy, and Spain are supported by strong life-science clusters, biobanks, hospitals, public research funding, and European research collaboration, while Russia maintains expertise in genomics, microbial ecology, and environmental microbiology despite geopolitical and procurement constraints.

China has scaled sequencing capacity and supports microbiome applications across healthcare, agriculture, food safety, and consumer health. India is expanding through genomics initiatives, pharmaceutical services, public health research, and cost-competitive bioinformatics talent. Japan and South Korea emphasize advanced sequencing, probiotics, aging-related research, medical technology, and high-quality clinical research infrastructure. Australia combines strong clinical research, agricultural genomics, marine and environmental microbiome programs, and biosecurity priorities, positioning it as a high-quality service hub in the Asia-Pacific region.

Actionable Recommendations for Industry Leaders

Industry leaders should invest in validated end-to-end workflows that connect collection kits, extraction protocols, sequencing depth, positive and negative controls, contamination assessment, and bioinformatics outputs. Clear service menus for 16S rRNA sequencing, shotgun metagenomics, metatranscriptomics, viromics, mycobiomics, and long-read sequencing help customers match study goals with budget, resolution, sample type, and turnaround requirements.

Providers should also build defensible data assets by improving metadata capture, adopting FAIR data principles, documenting pipeline versions, and offering secure cloud-based delivery with role-based access. Strategic partnerships with hospitals, contract research organizations, probiotic and nutrition companies, agritech firms, food safety laboratories, and public health agencies can expand demand. Commercial success will depend on scientific transparency, regulatory readiness, AI governance, consultative study design, and evidence-based reporting that customers can reproduce and audit.

Research Methodology

This executive summary is developed from secondary research using peer-reviewed microbiome literature, public genomics resources, regulatory guidance, sequencing technology documentation, and recognized institutional programs. Key evidence sources include public repositories such as NCBI Sequence Read Archive, EMBL-EBI resources, MGnify, established analytical frameworks, and documented applications across clinical, pharmaceutical, food, agriculture, environmental, and public health research.

The analysis prioritizes verifiable market signals: sequencing platform adoption, bioinformatics standardization, regional research capacity, data governance requirements, public funding activity, and application-specific demand. Insights are synthesized to support strategic planning for microbiome sequencing service providers, investors, laboratories, and enterprise buyers while avoiding unsupported market-size claims, market-share references, or speculative performance figures.

Conclusion

Microbiome sequencing services are moving from exploratory profiling to high-value biological intelligence that supports therapeutic development, precision nutrition, infectious disease research, agriculture, environmental monitoring, food safety, and public health. Sector advancement is being shaped by improved sequencing chemistry, long-read adoption, scalable bioinformatics, AI-enabled interpretation, stronger metadata standards, and increasing expectations for reproducibility.

The most competitive providers will combine scientific rigor with operational scalability. Organizations that can deliver validated workflows, secure data environments, transparent analytics, contamination-aware reporting, and regionally relevant expertise will be best positioned to capture demand as microbiome research becomes more integrated with precision medicine, product development, antimicrobial resistance surveillance, and global bioeconomy strategies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Microbiome Sequencing Services Market, by Sample Type
7.1. Introduction
7.2. Fecal
7.3. Oral
7.4. Skin
7.5. Soil
7.6. Water
8. Microbiome Sequencing Services Market, by Technology
8.1. Introduction
8.2. Amplicon Sequencing
8.2.1. 16S Rrna Sequencing
8.2.2. Internal Transcribed Spacer Sequencing
8.3. Metatranscriptomic Sequencing
8.4. Shotgun Metagenomic Sequencing
9. Microbiome Sequencing Services Market, by Application
9.1. Introduction
9.2. Agricultural & Animal Husbandry
9.2.1. Crop Quality Monitoring
9.2.2. Livestock Health Monitoring
9.3. Clinical Diagnostics
9.3.1. Gastrointestinal Disorder Diagnosis
9.3.2. Infectious Disease Diagnostics
9.4. Consumer Genomics
9.4.1. At-Home Testing
9.4.2. Clinic-Based Testing
9.5. Environmental Monitoring
9.5.1. Soil Health Monitoring
9.5.2. Water Quality Monitoring
9.6. Pharmaceutical R&D
9.6.1. Drug Discovery
9.6.2. Microbiome Therapeutics Development
10. Microbiome Sequencing Services Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Clinical Diagnostic Laboratories
10.4. Consumer Genomics Companies
10.5. Contract Research Organizations
10.6. Pharmaceutical & Biopharmaceutical Companies
11. Microbiome Sequencing Services Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Microbiome Sequencing Services Market, by Group
12.1. NATO
12.2. G7
12.3. BRICS
12.4. European Union
12.5. ASEAN
12.6. GCC
13. Microbiome Sequencing Services Market, by Country
13.1. China
13.2. United States
13.3. Japan
13.4. India
13.5. Germany
13.6. United Kingdom
13.7. Australia
13.8. France
13.9. South Korea
13.10. Italy
13.11. Canada
13.12. Russia
13.13. Brazil
13.14. Mexico
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Agilent Technologies, Inc.
15.2. BaseClear B.V.
15.3. BGI Genomics Co., Ltd.
15.4. Charles River Laboratories
15.5. Clinical Microbiomics A/S
15.6. CosmosID
15.7. Danaher Corporation
15.8. Eurofins Scientific SE
15.9. Genetic Analysis AS
15.10. Metabiomics Corp.
15.11. Microba Life Sciences
15.12. Microbiome Insights Inc.
15.13. MicroGenDX
15.14. Molecular Research LP
15.15. Molzym GmbH & Co. KG
15.16. Mérieux NutriSciences Corporation
15.17. Norgen Biotek
15.18. Novogene Co., Ltd.
15.19. Nucleome Informatics Pvt. Ltd.
15.20. Oxford Nanopore Technologies PLC
15.21. Pacific Bioscience of California, Inc.
15.22. PathoQuest
15.23. ProgenaBiome
15.24. Psomagen
15.25. QIAGEN N.V.
15.26. Rancho Biosciences
15.27. Resphera Biosciences, LLC
15.28. Shanghai Realbio Technology Co., Ltd.
15.29. Thermo Fisher Scientific, Inc.
15.30. Zymo Research Corporation
List of Figures
FIGURE 1. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL FECAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL FECAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL FECAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SKIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SKIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SKIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SOIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SOIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SOIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL WATER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL WATER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL WATER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL 16S RRNA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL 16S RRNA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL 16S RRNA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL INTERNAL TRANSCRIBED SPACER SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL INTERNAL TRANSCRIBED SPACER SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL INTERNAL TRANSCRIBED SPACER SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL METATRANSCRIPTOMIC SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL METATRANSCRIPTOMIC SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL METATRANSCRIPTOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SHOTGUN METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SHOTGUN METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SHOTGUN METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL AGRICULTURAL & ANIMAL HUSBANDRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL AGRICULTURAL & ANIMAL HUSBANDRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL AGRICULTURAL & ANIMAL HUSBANDRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CROP QUALITY MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CROP QUALITY MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CROP QUALITY MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL LIVESTOCK HEALTH MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL LIVESTOCK HEALTH MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL LIVESTOCK HEALTH MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL GASTROINTESTINAL DISORDER DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL GASTROINTESTINAL DISORDER DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL GASTROINTESTINAL DISORDER DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL AT-HOME TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL AT-HOME TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AT-HOME TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ENVIRONMENTAL MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ENVIRONMENTAL MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ENVIRONMENTAL MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SOIL HEALTH MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SOIL HEALTH MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SOIL HEALTH MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL WATER QUALITY MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL WATER QUALITY MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL WATER QUALITY MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL R&D MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL R&D MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL R&D MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MICROBIOME THERAPEUTICS DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MICROBIOME THERAPEUTICS DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL MICROBIOME THERAPEUTICS DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CLINICAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL CLINICAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL CLINICAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL CONSUMER GENOMICS COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CONSUMER GENOMICS COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CONSUMER GENOMICS COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 109. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 111. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 112. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 113. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 114. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 115. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 116. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 117. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 118. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 119. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 142. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 144. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 145. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 146. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 147. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 148. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 149. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 150. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 151. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 152. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 156. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 157. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 158. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 159. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 160. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 167. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 168. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 169. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 171. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 172. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 173. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 174. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 175. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 178. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 180. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 182. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 183. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 184. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 185. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 186. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 188. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 189. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 190. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 191. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 192. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 193. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 194. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 195. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 196. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 197. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 210. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 211. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 212. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 213. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 215. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 216. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 217. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 218. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 219. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 221. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 222. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 223. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 224. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 226. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 227. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 228. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 229. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 230. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 232. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 233. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 234. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 235. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 236. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 238. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 239. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 240. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 241. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 242. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 247. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 252. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 253. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 256. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 257. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 258. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 260. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 261. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 262. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 263. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 264. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 267. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 268. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 269. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 270. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 271. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 272. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 273. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 274. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 275. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 277. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 278. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 279. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 280. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 281. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 282. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 283. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 284. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 285. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 286. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 287. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 289. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 293. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 294. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 295. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 296. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 299. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 300. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 301. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 302. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 303. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 304. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 305. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 306. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 307. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 308. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 309. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 310. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 311. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 312. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2017-2032 (USD MILLION)
TABLE 313. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 314. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2017-2032 (USD MILLION)
TABLE 315. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 316. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2017-2032 (USD MILLION)
TABLE 317. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2017-2032 (USD MILLION)
TABLE 318. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2017-2032 (USD MILLION)
TABLE 319. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 320. SOUTH KOREA MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. SOUTH KO

Companies Mentioned

  • Agilent Technologies, Inc.
  • BaseClear B.V.
  • BGI Genomics Co., Ltd.
  • Charles River Laboratories
  • Clinical Microbiomics A/S
  • CosmosID
  • Danaher Corporation
  • Eurofins Scientific SE
  • Genetic Analysis AS
  • Metabiomics Corp.
  • Microba Life Sciences
  • Microbiome Insights Inc.
  • MicroGenDX
  • Molecular Research LP
  • Molzym GmbH & Co. KG
  • Mérieux NutriSciences Corporation
  • Norgen Biotek
  • Novogene Co., Ltd.
  • Nucleome Informatics Pvt. Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Bioscience of California, Inc.
  • PathoQuest
  • ProgenaBiome
  • Psomagen
  • QIAGEN N.V.
  • Rancho Biosciences
  • Resphera Biosciences, LLC
  • Shanghai Realbio Technology Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corporation

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 323.71 Million
Forecasted Market Value ( USD ) by 2032 $ 619.13 Million
Compound Annual Growth Rate11.3%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Cancer Microbiome Sequencing Market - Global Forecast 2026-2032 - Product Image

Cancer Microbiome Sequencing Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Microbiome Sequencing Services - Global Strategic Business Report - Product Image

Microbiome Sequencing Services - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From
Microbiome Sequencing Service Market Report 2026 - Product Image

Microbiome Sequencing Service Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Microbiome Sequencing Services Market Report by Technology, Research Type, Laboratory Type, Application, End User, and Region 2026-2034 - Product Image

Microbiome Sequencing Services Market Report by Technology, Research Type, Laboratory Type, Application, End User, and Region 2026-2034

  • Report
  • 142 Pages
  • Global
From
Microbiome Sequencing Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Microbiome Sequencing Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From

About the Microbiome Sequencing Market

The Microbiome Sequencing market is a subset of the biotechnology industry that focuses on the sequencing of microbial genomes. This technology is used to identify and characterize the microbial communities that inhabit the human body, as well as the environment. It is used to study the role of the microbiome in health and disease, and to develop new treatments and diagnostics. Microbiome sequencing is also used to identify and characterize microbial communities in food, water, and soil. The microbiome sequencing market is expected to grow rapidly in the coming years, driven by increasing investments in research and development, and the growing demand for personalized medicine. Additionally, the increasing prevalence of chronic diseases and the need for better diagnostics and treatments are expected to drive the market. Companies in the microbiome sequencing market include Illumina, Inc., Qiagen, Thermo Fisher Scientific, Inc., BGI, Eurofins Scientific, F. Hoffmann-La Roche Ltd., and Pacific Biosciences of California, Inc. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.